Lance Alstodt serves as Executive at BioRestorative Therapies, Inc., where they oversee executive responsibilities. Since joining the company, Lance Alstodt has executed 57 insider transactions totaling $138.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 5, 2019 involved purchasing 100 shares valued at $25.
Lance Alstodt currently holds 187,497 shares of BioRestorative Therapies, Inc. (BRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lance Alstodt has been a net buyer of BRTX stock. They have purchased $138.1K and sold $0 worth of shares.
Lance Alstodt's most recent insider trade was on Sep 5, 2019, when they purchased 100 shares at $0.25 per share.
Get notified when new Form 4 filings are submitted
| $0.27 |
| Discretionary |
| Aug 27, 2019 | BRTX | $999 | Purchase | 3,700 | $0.27 | Discretionary |
| Aug 27, 2019 | BRTX | $1.7K | Purchase | 6,200 | $0.28 | Discretionary |
| Aug 27, 2019 | BRTX | $26 | Purchase | 100 | $0.26 | Discretionary |
| Aug 21, 2019 | BRTX | $2.5K | Purchase | 9,900 | $0.25 | Discretionary |
| Aug 21, 2019 | BRTX | $23 | Purchase | 100 | $0.23 | Discretionary |